Optibiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; CholBiome, an ingredient for use in a range of functional food products and supplements in consumer and pharmaceutical health care; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galacto oligosaccharide that are used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; and Sweetbiotix, a sweetener for use in food products and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. Optibiotix Health Plc was founded in 2012 and is headquartered in York, the United Kingdom.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-20-79338780
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£196,765.00
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date4/22/2019 (Estimated)
OptionableNot Optionable
OptiBiotix Health (LON:OPTI) Frequently Asked Questions
What is OptiBiotix Health's stock symbol?
OptiBiotix Health trades on the London Stock Exchange (LON) under the ticker symbol "OPTI."
When is OptiBiotix Health's next earnings date?
Has OptiBiotix Health been receiving favorable news coverage?
Media coverage about OPTI stock has trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. OptiBiotix Health earned a media sentiment score of 1.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days.
Who are some of OptiBiotix Health's key competitors?
Some companies that are related to OptiBiotix Health include IMV (IMV), Gamida Cell (GMDA), Enochian Biosciences (ENOB), Monash IVF Group (MVF), Kodiak Sciences (KOD), Horizon Discovery Group (HZD), Affimed (AFMD), Verastem (VSTM), Emblem (EMC), Xenon Pharmaceuticals (XENE), 22nd Century Group (XXII), BioTime (BTX), BELLUS Health (BLU), ProMetic Life Sciences (PLI) and MediGene (MDG1).
What other stocks do shareholders of OptiBiotix Health own?
Who are OptiBiotix Health's key executives?
OptiBiotix Health's management team includes the folowing people:
- Mr. Stephen Patrick O'Hara, Founder, CEO & Exec. Director
- Mr. Mark Kingsley Collingbourne, Chief Financial Officer (Age 53)
- Kevin James Newman, Corp. Devel. Director
- Ms. Christina Mary Wood, Sales & Marketing Director and Director (Age 59)
- Mr. Steven Riley, Head of Online Sales & Marketing
How do I buy shares of OptiBiotix Health?
Shares of OPTI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is OptiBiotix Health's stock price today?
One share of OPTI stock can currently be purchased for approximately GBX 83.50.
How big of a company is OptiBiotix Health?
OptiBiotix Health has a market capitalization of £70.75 million and generates £196,765.00 in revenue each year.
What is OptiBiotix Health's official website?
How can I contact OptiBiotix Health?
OptiBiotix Health's mailing address is Innovation Centre, Innovation Way, HESLINGTON, YO10 5DG, United Kingdom. The company can be reached via phone at +44-20-79338780.
MarketBeat Community Rating for OptiBiotix Health (LON OPTI)
MarketBeat's community ratings are surveys of what our community members think about OptiBiotix Health and other stocks. Vote "Outperform" if you believe OPTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OPTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
